VINCENT GALIANO: Open Payments
NPI 1821027921 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$333 in 17 payments from 10 companies in 2025. Trend: 2023 $350 · 2024 $288 · 2025 $333
Food & beverage: $333
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $103 |
| Exact Sciences Corporation | 2 | $41 |
| Novo Nordisk Inc | 2 | $36 |
| ABBVIE INC. | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Dexcom, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| Lundbeck LLC | 1 | $18 |
| CeQur Corporation | 2 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: CAPLYTA, REXULTI, Cologuard Collection Kit, UBRELVY, Dexcom G6 Transmitter, JARDIANCE, CeQur Simplicity, FARXIGA.
Industry payments across FL — which companies pay providers there.
